RAP1A and prostate neoplasm: Furthermore, our studies suggest that 8CPT treatment can inhibit angiogenesis via two different mechanisms involving PKA activation in prostate tumor cells, as shown here, and Epac/Rap1 activation in endothelial cells [8].